Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma

SIMPLE SUMMARY: Urothelial carcinoma (UC) is a common type of bladder cancer. Patients with UC that has not improved after previous treatment or has spread to other parts of the body need new treatment options. Ibrutinib is a drug approved for the treatment of blood cancers and chronic graft-versus-...

Descripción completa

Detalles Bibliográficos
Autores principales: Mar, Nataliya, Zakharia, Yousef, Falcon, Alejandro, Morales-Barrera, Rafael, Mellado, Begona, Duran, Ignacio, Oh, Do-Youn, Williamson, Stephen K., Gajate, Pablo, Arkenau, Hendrik-Tobias, Jones, Robert J., Teo, Min Yuen, Turan, Tolga, McLaughlin, Robert T., Peltier, Hillary M., Chong, Elizabeth, Atluri, Harisha, Dean, James P., Castellano, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251876/
https://www.ncbi.nlm.nih.gov/pubmed/37296940
http://dx.doi.org/10.3390/cancers15112978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251876/
https://www.ncbi.nlm.nih.gov/pubmed/37296940
http://dx.doi.org/10.3390/cancers15112978

Ejemplares similares